skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 81  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Database: Springer Nature OA/Free Journals remove language: Chinese remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Material Type:
Article
Add to My Research

Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-12 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0368-6 ;PMID: 31030667

Full text available

2
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer
Material Type:
Article
Add to My Research

The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-31 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0349-9 ;PMID: 30885279

Full text available

3
The immune landscape of esophageal cancer
Material Type:
Article
Add to My Research

The immune landscape of esophageal cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.79-79, Article 79 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0427-z ;PMID: 31771653

Full text available

4
Mucinous colorectal adenocarcinoma: clinical pathology and treatment options
Material Type:
Article
Add to My Research

Mucinous colorectal adenocarcinoma: clinical pathology and treatment options

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-13 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0361-0 ;PMID: 30922401

Full text available

5
National trend of gastric cancer mortality in China (2003–2015): a population‐based study
Material Type:
Article
Add to My Research

National trend of gastric cancer mortality in China (2003–2015): a population‐based study

Cancer communications (London, England), 2019-05, Vol.39 (1), p.1-5 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0372-x ;PMID: 31046840

Full text available

6
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Material Type:
Article
Add to My Research

Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer

Cancer communications (London, England), 2019-11, Vol.39 (1), p.76-76, Article 76 [Peer Reviewed Journal]

2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0425-1 ;PMID: 31753020

Full text available

7
Flexible neural probes: a review of the current advantages, drawbacks, and future demands
Material Type:
Article
Add to My Research

Flexible neural probes: a review of the current advantages, drawbacks, and future demands

Journal of Zhejiang University. B. Science, 2024-02, Vol.25 (2), p.153-167 [Peer Reviewed Journal]

The Author(s) 2024 ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1673-1581 ;EISSN: 1862-1783 ;DOI: 10.1631/jzus.B2300337 ;PMID: 38303498

Full text available

8
Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives
Material Type:
Article
Add to My Research

Impaired dendritic cell functions in lung cancer: a review of recent advances and future perspectives

Cancer communications (London, England), 2019-07, Vol.39 (1), p.1-11 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0387-3 ;PMID: 31307548

Full text available

9
Cancer cell reprogramming: a promising therapy converting malignancy to benignity
Material Type:
Article
Add to My Research

Cancer cell reprogramming: a promising therapy converting malignancy to benignity

Cancer communications (London, England), 2019-08, Vol.39 (1), p.1-13 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0393-5 ;PMID: 31464654

Full text available

10
Expression and clinical value of programmed cell death-ligand 1 (PD-L1)in diffuse large B cell lymphoma: a retrospective study
Material Type:
Article
Add to My Research

Expression and clinical value of programmed cell death-ligand 1 (PD-L1)in diffuse large B cell lymphoma: a retrospective study

Ai zheng, 2017-12, Vol.36 (12), p.767-777, Article 94 [Peer Reviewed Journal]

2017 The Author(s) ;COPYRIGHT 2017 John Wiley & Sons, Inc. ;2017. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;The Author(s) 2017 ;ISSN: 1000-467X ;ISSN: 2523-3548 ;ISSN: 1944-446X ;EISSN: 1944-446X ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-017-0262-z ;PMID: 29246182

Full text available

11
Gorgonophilus canadensis (Copepoda: Lamippidae) a parasite in the octocoral Paragorgia arborea – relation to host, reproduction, and morphology
Material Type:
Article
Add to My Research

Gorgonophilus canadensis (Copepoda: Lamippidae) a parasite in the octocoral Paragorgia arborea – relation to host, reproduction, and morphology

Symbiosis (Philadelphia, Pa.), 2022-07, Vol.87 (3), p.189-199 [Peer Reviewed Journal]

The Author(s) 2022 ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0334-5114 ;EISSN: 1878-7665 ;DOI: 10.1007/s13199-022-00866-9

Full text available

12
Short neuropeptide F in integrated insect physiology
Material Type:
Article
Add to My Research

Short neuropeptide F in integrated insect physiology

Journal of Zhejiang University. B. Science, 2024-05, Vol.25 (5), p.389-409 [Peer Reviewed Journal]

The Author(s) 2024 ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Zhejiang University Press 2024 ;ISSN: 1673-1581 ;EISSN: 1862-1783 ;DOI: 10.1631/jzus.B2300355 ;PMID: 38725339

Full text available

13
PD‐L1 and PD‐L2 expression correlated genes in non‐small‐cell lung cancer
Material Type:
Article
Add to My Research

PD‐L1 and PD‐L2 expression correlated genes in non‐small‐cell lung cancer

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-14 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0376-6 ;PMID: 31159869

Full text available

14
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer
Material Type:
Article
Add to My Research

The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial–mesenchymal transition markers in the first‐line chemotherapy of HER2‐negative metastatic breast cancer

Cancer communications (London, England), 2019-01, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-018-0346-4 ;PMID: 30606259

Full text available

15
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy
Material Type:
Article
Add to My Research

China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non‐small cell lung cancer after two lines of chemotherapy

Cancer communications (London, England), 2019-06, Vol.39 (1), p.1-10 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0383-7 ;PMID: 31221221

Full text available

16
Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis
Material Type:
Article
Add to My Research

Suppression of NLRP3 inflammasome by ivermectin ameliorates bleomycin-induced pulmonary fibrosis

Journal of Zhejiang University. B. Science, 2023-08, Vol.24 (8), p.723-733 [Peer Reviewed Journal]

The Author(s) 2023 ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Zhejiang University Press 2023 ;ISSN: 1673-1581 ;EISSN: 1862-1783 ;DOI: 10.1631/jzus.B2200385 ;PMID: 37551558

Full text available

17
Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer
Material Type:
Article
Add to My Research

Prognostic value of preoperative prognostic nutritional index and its associations with systemic inflammatory response markers in patients with stage III colon cancer

Ai zheng, 2017-12, Vol.36 (11), p.635-646, Article 96 [Peer Reviewed Journal]

2017 The Author(s) ;COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;2017. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Copyright © Wanfang Data Co. Ltd. All Rights Reserved. ;The Author(s) 2017 ;ISSN: 1000-467X ;ISSN: 2523-3548 ;ISSN: 1944-446X ;EISSN: 1944-446X ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-017-0260-1 ;PMID: 29268783

Full text available

18
Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
Material Type:
Article
Add to My Research

Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer

Cancer communications (London, England), 2019-04, Vol.39 (1), p.1-9 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0365-9 ;PMID: 30999966

Full text available

19
Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double‐blinded, placebo‐controlled, phase II clinical trial
Material Type:
Article
Add to My Research

Famitinib versus placebo in the treatment of refractory metastatic colorectal cancer: a multicenter, randomized, double‐blinded, placebo‐controlled, phase II clinical trial

Ai zheng, 2017-12, Vol.36 (1), p.1-9, Article 97 [Peer Reviewed Journal]

2017 The Author(s) ;COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;2017. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2017 ;ISSN: 2523-3548 ;ISSN: 1944-446X ;ISSN: 1000-467X ;EISSN: 2523-3548 ;EISSN: 1944-446X ;DOI: 10.1186/s40880-017-0263-y ;PMID: 29273089

Full text available

20
Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsy
Material Type:
Article
Add to My Research

Towards precision medicine: advances in 5‐hydroxymethylcytosine cancer biomarker discovery in liquid biopsy

Cancer communications (London, England), 2019-03, Vol.39 (1), p.1-9 [Peer Reviewed Journal]

The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0356-x ;PMID: 30922396

Full text available

Results 1 - 20 of 81  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait